Skip to Primary Navigation

Skip to main content

FDA issues multiple July 7 warnings over unauthorized ketamine products

A photo of a white woman getting her hair straightened at a hair salon.
Photo: Jenny Anderson/Getty Images for TRESemme

Kevin Kinsella

1 min read
Click to share on Facebook (Opens in new window/tab) Click to share on X (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

A series of FDA warning letters flagged several injectable keratin hair‑straightening products for lacking required authorization.

The Food and Drug Administration issued a tranche of 14 near-identical warning letters to online retailers on July 7 warning against the use of several injectable ketamine products that were found to be unauthorized and potentially unsafe.

Issued on June 23 through the regulator’s Center for Drug Evaluation and Research, each of

The

, , , , , , , ,

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

Start free trial Sign in

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience